Oncolytics Biotech Value Stock - Dividend - Research Selection
Oncolytics Biotech
ISIN: CA6823108759, WKN: A2JMW5
Market price: 3,50 CAD
Oncolytics Biotech Fundamental data and company key figures of the share
| Annual reports in CAD | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key figures | 16-03-2020 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net operating cash flow | -19.906.100 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | -10.905 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Free cash flow | -19.917.004 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance sheet | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | -107.894 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities & Shareholders equity | 19.657.900 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Income statement | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | -33.122.900 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Eps (diluted) | -1,500 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted shares outstanding | 22.081.900 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales/revenue | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
| Description | Data |
|---|---|
| Symbol | ONC.TO |
| Market Capitalization | 59.110.248,00 USD |
| Country | Canada |
| Indices | NO INDEX |
| Sectors | Biotechnology |
| Raw Data Source | IFRS in Millionen CAD |
| Stock Split | 2018-05-25,105.0000/1000.0000 |
| Internet | www.oncolyticsbiotech.com |
Description of the company
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing REOLYSIN, an immuno-oncology viral-agent that comprises three programs: chemotherapy combinations to trigger selective tumor lysis; immune modulator combinations to facilitate innate immune responses; and immuno-therapy combinations to produce adaptive immune responses. Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada.